Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 16/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.44 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.44 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.44 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2887923 | 0.91 | ELANE (0.79) | ELANECYP2C9CYP3A4ALDH1A1ADRB1 | |
| SCHEMBL8227499 | 0.86 | ELANE (0.64) | ELANECYP2C9CYP3A4ALDH1A1ADRB1 | |
| SCHEMBL9914390 | 0.86 | ELANE (0.64) | ELANECYP2C9CYP3A4ALDH1A1ADRB1 | |
| SCHEMBL8053053 | 0.86 | ELANE (0.64) | ELANECYP2C9CYP3A4ALDH1A1ADRB1 | |
| SCHEMBL6295870 | 0.84 | ELANE (0.81) | ELANECYP2C9CYP3A4 | |
| SCHEMBL1134170 | 0.84 | ELANE (0.81) | ELANECYP2C9CYP3A4 | |
| SCHEMBL8050837 | 0.81 | ELANE (0.79) | ELANECYP2C9CYP3A4ALDH1A1ADRB1 | |
| SCHEMBL2888564 | 0.81 | ELANE (0.79) | ELANECYP2C9CYP3A4ALDH1A1ADRB1 | |
| SCHEMBL9914387 | 0.81 | ELANE (0.79) | ELANECYP2C9CYP3A4ALDH1A1ADRB1 | |
| SCHEMBL14899949 | 0.81 | ELANE (0.82) | ELANECYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1546113-B1 | PYRIMIDINONE DERIVATIVES AS THERAPEUTIC AGENTS AGAINST ACUTE AND CHRONIC INFLAMMATORY, ISCHAEMIC AND REMODELLING PROCESSES | BAYER IP GMBH (DE) | 2013-05-01 | — | — | EP | disclosed |